OncoSec Board Rejects Alpha Holdings “Proposal” and Announces New Special Meeting Date
Believes Alpha’s Contingency-Laden “Proposal” is a Blatant Attempt to Mislead Shareholders into Giving Alpha Control of OncoSec Before Alpha Makes…
Pharmaceuticals, Biotechnology and Life Sciences
Believes Alpha’s Contingency-Laden “Proposal” is a Blatant Attempt to Mislead Shareholders into Giving Alpha Control of OncoSec Before Alpha Makes…
DUBLIN–(BUSINESS WIRE)–The “Protein Phosphatase 2A (PP2A or EC 3.1.3.16) – Pipeline Review, H2 2019” drug pipelines has been added to…
DUBLIN–(BUSINESS WIRE)–The “Lymphocyte Activation Gene 3 Protein – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
AUXVASSE, Mo.–(BUSINESS WIRE)–#CRO–Sinclair Research, a leading provider of nonclinical contract research services, today announced an agreement to acquire the assets…
Complete Responses Noted in Multiple Tumor Types (including Pancreatic Cancer, Triple Negative Breast Cancer, Head and Neck Cancer, Merkel Cell…
Together, Charles River and Fios Genomics aim to accelerate preclinical discovery and development by turning complex data into actionable information…
DUBLIN–(BUSINESS WIRE)–The “Neuronal Acetylcholine Receptor Subunit Beta 2 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Type 2 Angiotensin II Receptor – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Lysophosphatidic Acid Receptor 1 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary…
DUBLIN–(BUSINESS WIRE)–The “Hepcidin – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary Hepcidin (Liver Expressed…